This is a news story, published by CNBC, that relates primarily to Novo Nordisk news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
profit growth. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Novo Nordisk news, net profit news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
net profit increaseCNBC
•
76% Informative
Novo Nordisk posted weaker-than-expected net profit in the second quarter of 2024 .
Pharmaceutical giant said its net profit came in at 20.05 billion Danish kroner ( $2.93 billion ) in the three months to the end of June .
The pharmaceutical giant also trimmed its operating profit outlook for the full-year 2024 , saying growth was now anticipated to come in between 20% and 28% .
VR Score
88
Informative language
96
Neutral language
27
Article tone
formal
Language
English
Language complexity
44
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links